1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Gene Amplification Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Research Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Premium Insights
3.1 Geographical Snapshot: Global Gene Amplification Technologies Market
3.2 Technology Segment: Market Attractiveness Index
3.3 Sample Type Segment: Market Attractiveness Index
3.4 End-User Segment: Market Attractiveness Index
3.5 Business Type Segment: Market Attractiveness Index
3.6 Application Segment: Market Attractiveness Index
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Supply Chain Overview
4.4 Value Chain Overview
4.4.1 Cold Chain
4.5 Recent Trends and Developments
4.6 COVID-19 Impact Analysis
4.7 Porter’s Five Forces Analysis
4.7.1 Supplier Power
4.7.2 Buyer Power
4.7.3 Competitive Rivalry
4.7.4 Threat from Substitutes
4.7.5 Threat of New Entrants
4.8 PESTLE Analysis
4.8.1 Political Factors
4.8.2 Economic Factors
4.8.3 Social Factors
4.8.4 Technological Factors
4.8.5 Legal Factors
4.8.6 Environmental Factors
5 Global Gene Amplification Technologies Market Analysis by Application
5.1 Key Findings
5.2 Global Market Outlook
5.3 Region Segment Growth Prospects
5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033
5.5 Global Gene Amplification Technologies Market Share Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast
5.6.1 Pre-COVID-19 Market Scenario
5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Gene Amplification Technologies Market Analysis by Technology
6.1 Key Findings
6.2 Global Technology Market Outlook
6.3 Global Gene Amplification by Technology Market Attractiveness Index
6.4 Regional Market Size Estimation and Forecast
6.5 Amplification based on PCR
6.5.2 Global PCR-based Amplification Market Forecast
6.5.3 Global Cleavable Linkers Market Forecast by Region
6.6 Loop-mediated Isothermal Amplification
6.7 Global Loop-mediated Isothermal Amplification Market Forecast
6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region
6.8 Nucleic Acid Sequence Based Amplification
6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast
6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region
6.9 Strand Displacement Amplification
6.8.3 Strand Displacement Amplification Market Forecast
6.8.4 Global Strand Displacement Amplification Market Forecast by Region
6.10 Multiple Displacement Amplification
6.10.1 Multiple Displacement Amplification Market Forecast
6.8.5 Global Multiple Displacement Amplification Market Forecast by Region
6.11 Other Technology Amplification
6.8.6 Other Technology Amplification Market Forecast
7 Global Gene Amplification Technologies Market Analysis by Sample Type
7.1 Key Findings
7.2 Global Sample Type Market Outlook
7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index
7.3 Global Gene Amplification Technologies Market by Sample Type
7.4 Single Cell
7.4.1 Global Single Cell Market Forecast
7.4.2 Global Single Cell Market Forecast by Region
7.5 Formalin-Fixed, Paraffin-Embedded (FFPE)
7.5.1 Global FFPE Market Forecast
7.5.2 Global FFPE Market Forecast by Region
8 Global Gene Amplification Technologies Market Analysis by End-User
8.1 Key Findings
8.2 Global End-User Market Outlook
8.2.1 Global Gene Amplification by End-User Market Attractiveness Index
8.3 Global Gene Amplification Technologies Market by End-User Antigen
8.4 Pharmaceutical & Biotechnological Companies
8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast
8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region
8.5 Academic & Research Institute
8.5.1 Global Academic & Research Institute Market Forecast
8.5.2 Global Academic & Research Institute Market Forecast by End-User
9 Global Gene Amplification Technologies Market Analysis by Business Type
9.1 Key Findings
9.2 Global Business Type Market Outlook
9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index
9.3 Global Gene Amplification Technologies Market by Business Type
9.4 Kits & Reagents
9.4.1 Global Kits & Reagents Market Forecast
9.4.2 Global Kits & Reagents Market by Region
9.5 Instruments
9.5.1 Global Instruments Market Forecast
9.5.2 Global Instruments Market by Region
9.6 Services
9.6.1 Global Services Market Forecast
9.6.2 Global Services Market by Region
9.7 Ancillaries
9.7.1 Global Ancillaries Market Forecast
9.7.2 Global Ancillaries Market by Region
10 North America Market Analysis
10.1 Key Findings
10.2 Overview
10.2.2 North America Gene Amplification Technologies Market Attractiveness Index
10.3 North America Gene Amplification Technologies Market Size and Forecast by Value
10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country
10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application
10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
10.10 US Market
10.10.1 The US Government’s Foreign Investment Risk
10.10.2 The American Pharmaceutical Research and Manufacturers
10.11 Canada Market
10.11.1 Control of Laboratory-Developed Tests
10.11.2 Drug-related Expenses
11 Europe Market Analysis
11.1 Key Findings
11.2 Overview
11.3 Europe Gene Amplification Technologies Market Attractiveness Index
11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country
11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value
11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User
11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application
11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology
11.2 Germany Market
11.2.1 Germany Has a Robust and Broad Market
11.2.2 Inventive IVD industry
11.3 UK Market
11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs)
11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis
11.4 France Market
11.4.1 Molecular Diagnostics Market Expansion in France
11.4.2 Foreign Organisations Investing in France
11.5 Italy Market
11.5.1 Italian Pharmaceuticals’ Advantage
11.5.2 Nucleic Acid Amplification Technology’s (NAT) Effects in Italy
11.6 Spain Market
11.6.1 Spanish Clinical Genetics and Genomics
11.6.2 Expansion of Spain’s pharmaceutical and R&D Industries
11.15 Rest of Europe Market Analysis
12 Asia-Pacific Market Analysis
12.1 Key Findings
12.2 Overview
12.2.1 The Commercial Effect of Polymerase Chain Reactions
12.2.2 Asia-Pacific Market for Gene Therapy
12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value
12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User
12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application
12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology
12.3 China Market
12.3.1 China’s Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations
12.3.2 Market Segment Analysis for Molecular Diagnostics
12.4 India Market
12.4.1 Advancements in POC Diagnostic Technology
12.4.2 India’s Genome Engineering Technology Regulations
12.5 Japan Market
12.5.1 Japan’s Ability to Use Genomic Medicine
12.5.2 Developments in Japanese Genetic Testing Regulation
12.14 South Korea Market
12.5.3 Pharmaceutical Industry Development in South Korea
12.6 Australia Market
12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection
12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach
12.7 Rest of Asia-Pacific Market Analysis
13 Middle East & Africa Market Analysis
13.1 Key Findings
13.2 Overview
13.2.1 MENA’s Expanding Pharmaceutical Industry
13.2.2 MENA’s Regulatory Environment
13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value
13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country
13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User
13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application
13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology
13.3 South Africa Market Analysis
13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market
13.4 Saudi Arabia Market Analysis
13.4.1 Pharmacy Research and Development of Saudi Arabia
13.4.2 Rules and Regulations
13.5 Turkey Market Analysis
13.5.1 Turkish Regulatory Authority
13.5.2 Updates to the Recommendations for PCR Testing
13.6 Rest of Middle East and Africa Market Analysis
14 Latin America Market Analysis
14.1 Key Findings
14.2 Overview
14.2.1 Significantly Raise in Latin American Pharmaceutical Industry
14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts
14.3 Latin America Gene Amplification Technologies Market Attractiveness Index
14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value
14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country
14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application
14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
14.11 Brazil Market
14.2.3 Brazil’s Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis
14.2.4 Brazilian Government Regulations and Policies
14.3 Mexico Market
14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances
14.13 Rest of Latin America Market Analysis
15 Competitive Landscape
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Collaboration
15.5 Key Business Strategy Analysis- Expansion
15.6 Key Business Strategy Analysis- Investment
15.7 Key Business Strategy Analysis- New Product Launch
15.8 Key Business Strategy Analysis- Partnership
15.9 Key Business Strategy Analysis- Development
15.10 Key Business Strategy Analysis- Joint Venture
16 Company Profiles
16.1 Merck KGaA
16.1.2 Company Snapshot
16.1.3 Company Overview
16.1.4 Financial Analysis
16.1.5 Product Benchmarking
16.1.6 Strategic Outlook
16.2 4BASEBIO AG
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Abbott Laboratories (U.S.)
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Agilent Technologies, Inc. (U.S.)
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Ambion Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.5.4 Strategic Outlook
16.6 Bayer Pharmaceutics
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Becton Dickinson and Co.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.8.4 Product Benchmarking
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Bio-Rad Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.5 Strategic Outlook
16.9 MyBioSource
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Product Benchmarking
16.9.4 Strategic Outlook
16.10 Danaher Corporation
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Illumina Inc.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 LGC Group
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.12.4 Strategic Outlook
16.13 Nanjing Vazyme Biotech Co.
16.13.1 Company Snapshot
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 New England Biolabs
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.14.4 Strategic Outlook
16.15 PerkinElmer Inc.
16.15.1 Company Snapshot
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook
16.16 Promega Corporation
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Strategic Outlook
16.17 Qiagen N.V.
16.17.1 Company Snapshot
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
16.17.5 Strategic Outlook
16.18 Silicon Biosystems
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.18.4 Strategic Outlook
16.19 Takara Bio Inc.
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.4 Product Benchmarking
16.19.5 Strategic Outlook
16.20 Yikang Inc.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Product Benchmarking
16.20.4 Strategic Outlook
17 Conclusion and Recommendations
17.1 Concluding Remarks from
17.2 Recommendations for Market Players
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer